Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy.
Galbán CJ, Ma B, Malyarenko D, Pickles MD, Heist K, Henry NL, Schott AF, Neal CH, Hylton NM, Rehemtulla A, Johnson TD, Meyer CR, Chenevert TL, Turnbull LW, Ross BD. Galbán CJ, et al. Among authors: neal ch. PLoS One. 2015 Mar 27;10(3):e0122151. doi: 10.1371/journal.pone.0122151. eCollection 2015. PLoS One. 2015. PMID: 25816249 Free PMC article. Clinical Trial.
Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).
Rahbar H, Zhang Z, Chenevert TL, Romanoff J, Kitsch AE, Hanna LG, Harvey SM, Moy L, DeMartini WB, Dogan B, Yang WT, Wang LC, Joe BN, Oh KY, Neal CH, McDonald ES, Schnall MD, Lehman CD, Comstock CE, Partridge SC. Rahbar H, et al. Among authors: neal ch. Clin Cancer Res. 2019 Mar 15;25(6):1756-1765. doi: 10.1158/1078-0432.CCR-18-2967. Epub 2019 Jan 15. Clin Cancer Res. 2019. PMID: 30647080 Free PMC article. Clinical Trial.
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
McDonald ES, Romanoff J, Rahbar H, Kitsch AE, Harvey SM, Whisenant JG, Yankeelov TE, Moy L, DeMartini WB, Dogan BE, Yang WT, Wang LC, Joe BN, Wilmes LJ, Hylton NM, Oh KY, Tudorica LA, Neal CH, Malyarenko DI, Comstock CE, Schnall MD, Chenevert TL, Partridge SC. McDonald ES, et al. Among authors: neal ch. Radiology. 2021 Jan;298(1):60-70. doi: 10.1148/radiol.2020202465. Epub 2020 Nov 17. Radiology. 2021. PMID: 33201788 Free PMC article.
Factors Affecting Image Quality and Lesion Evaluability in Breast Diffusion-weighted MRI: Observations from the ECOG-ACRIN Cancer Research Group Multisite Trial (A6702).
Whisenant JG, Romanoff J, Rahbar H, Kitsch AE, Harvey SM, Moy L, DeMartini WB, Dogan BE, Yang WT, Wang LC, Joe BN, Wilmes LJ, Hylton NM, Oh KY, Tudorica LA, Neal CH, Malyarenko DI, McDonald ES, Comstock CE, Yankeelov TE, Chenevert TL, Partridge SC. Whisenant JG, et al. Among authors: neal ch. J Breast Imaging. 2020 Dec 24;3(1):44-56. doi: 10.1093/jbi/wbaa103. eCollection 2021 Jan-Feb. J Breast Imaging. 2020. PMID: 33543122 Free PMC article.
Imaging of breast cancer-related changes after surgical therapy.
Neal CH, Yilmaz ZN, Noroozian M, Klein KA, Sundaram B, Kazerooni EA, Stojanovska J. Neal CH, et al. AJR Am J Roentgenol. 2014 Feb;202(2):262-72. doi: 10.2214/AJR.13.11517. AJR Am J Roentgenol. 2014. PMID: 24450664 Review.
Imaging of breast cancer-related changes after nonsurgical therapy.
Yilmaz ZN, Neal CH, Noroozian M, Klein KA, Sundaram B, Kazerooni EA, Stojanovska J. Yilmaz ZN, et al. Among authors: neal ch. AJR Am J Roentgenol. 2014 Mar;202(3):675-83. doi: 10.2214/AJR.13.11518. AJR Am J Roentgenol. 2014. PMID: 24555607 Review.
40 results